ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.652,67
0,44%
S&P 500
5.352,96
-0,02%
Dow Jones
38.886,17
0,20%
Euro vs US Dollar
1,08916
0,16%
Bitcoin
70.619,15
-0,65%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Microbot Medical Inc (MBOT)

  7. Microbot Medical Inc (MBOT) News

MBOT

Microbot Medical (MBOT)

Microbot Medical Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:MBOT
DatumZeitQuelleÜberschriftSymbolFirma
04/06/202422h35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBOTMicrobot Medical Inc
04/06/202422h20GlobeNewswire Inc.Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq RulesNASDAQ:MBOTMicrobot Medical Inc
04/06/202414h30Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:MBOTMicrobot Medical Inc
03/06/202422h01Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:MBOTMicrobot Medical Inc
03/06/202418h11GlobeNewswire Inc.Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq RulesNASDAQ:MBOTMicrobot Medical Inc
03/06/202414h20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBOTMicrobot Medical Inc
03/06/202414h20GlobeNewswire Inc.Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical TrialNASDAQ:MBOTMicrobot Medical Inc
16/05/202422h30Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MBOTMicrobot Medical Inc
15/05/202414h45Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MBOTMicrobot Medical Inc
29/04/202414h30GlobeNewswire Inc.Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health™NASDAQ:MBOTMicrobot Medical Inc
15/04/202414h30GlobeNewswire Inc.Microbot Medical Shares Status Following Recent Geopolitical EventsNASDAQ:MBOTMicrobot Medical Inc
27/02/202400h41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MBOTMicrobot Medical Inc
27/02/202400h41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MBOTMicrobot Medical Inc
27/02/202400h41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MBOTMicrobot Medical Inc
27/02/202400h41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MBOTMicrobot Medical Inc
20/02/202422h35Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:MBOTMicrobot Medical Inc
14/02/202420h49Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MBOTMicrobot Medical Inc
05/02/202413h30GlobeNewswire Inc.Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the USNASDAQ:MBOTMicrobot Medical Inc
30/01/202422h30Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MBOTMicrobot Medical Inc
30/01/202413h20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBOTMicrobot Medical Inc
30/01/202413h20GlobeNewswire Inc.Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal MattersNASDAQ:MBOTMicrobot Medical Inc
26/01/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MBOTMicrobot Medical Inc
22/01/202423h20Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:MBOTMicrobot Medical Inc
18/01/202413h20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBOTMicrobot Medical Inc
18/01/202413h20GlobeNewswire Inc.Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical StudyNASDAQ:MBOTMicrobot Medical Inc
12/01/202422h20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBOTMicrobot Medical Inc
12/01/202422h16Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:MBOTMicrobot Medical Inc
02/01/202423h00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MBOTMicrobot Medical Inc
02/01/202422h55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBOTMicrobot Medical Inc
29/12/202314h00GlobeNewswire Inc.Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for $2.73 Million in Gross Proceeds Priced At-the-Market Under Nasdaq RulesNASDAQ:MBOTMicrobot Medical Inc
 Showing the most relevant articles for your search:NASDAQ:MBOT

Kürzlich von Ihnen besucht

COIN
HELLOUST
HELLO
NASDAQ
PHO
Invesco Water Resources ...
USOTC
ATOXF
Durango Resources (QB)
LSE
71KN
Saffron Hsg 48
COIN
WRXBTC
WazirX Token
BIT
P1WY71
NLBNPIT1WY71 20240920 90
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten